Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,529 | 69,290 | 73,820 | 79,515 | 93,980 |
| Marketable Securities | 76,122 | 89,081 | 89,808 | 79,576 | 61,490 |
| Receivables | 33,561 | 39,399 | 20,663 | 47,272 | 30,437 |
| Inventories | 27,982 | 29,215 | 32,241 | 41,715 | 39,374 |
| TOTAL | $235,830 | $233,042 | $220,609 | $252,051 | $231,123 |
| Non-Current Assets | |||||
| PPE Net | 41,267 | 39,930 | 39,618 | 38,382 | 36,748 |
| Investments And Advances | 47,524 | 35,339 | 36,443 | 43,219 | 31,848 |
| Other Non-Current Assets | 31,606 | 30,120 | 29,357 | 17,633 | 15,291 |
| TOTAL | $120,397 | $105,389 | $105,418 | $99,234 | $83,887 |
| Total Assets | $356,227 | $338,431 | $326,027 | $351,285 | $315,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,774 | 22,200 | 24,590 | 35,611 | 22,445 |
| Accrued Expenses | 59,123 | 50,388 | 46,548 | 54,825 | 51,611 |
| TOTAL | $77,897 | $72,588 | $71,138 | $90,436 | $74,056 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,608 | 7,380 | 7,390 | 8,544 | 7,831 |
| TOTAL | $7,608 | $7,380 | $7,390 | $8,544 | $7,831 |
| Total Liabilities | $85,505 | $79,968 | $78,528 | $98,980 | $81,887 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,770 | 71,595 | 71,546 | 71,510 | 72,031 |
| Common Shares | 718 | 716 | 715 | 719 | 720 |
| Retained earnings | 16,316 | 13,391 | 7,364 | 5,074 | -13,068 |
| Other shareholders' equity | -95 | 63 | -7 | -173 | 12 |
| TOTAL | $270,722 | $258,463 | $247,499 | $252,305 | $233,123 |
| Total Liabilities And Equity | $356,227 | $338,431 | $326,027 | $351,285 | $315,010 |